Barry D. Quart
2021
Compensation breakdown
| Non-Equity Incentive Plan | $392,000 |
|---|---|
| Option Awards | $2,268,479 |
| Salary | $700,000 |
| Stock Awards | $2,061,649 |
| Other | $8,700 |
| Total | $5,430,828 |
Quart received $2.3M in option awards, accounting for 42% of the total pay in 2021.
Quart also received $392K in non-equity incentive plan, $700K in salary, $2.1M in stock awards and $8.7K in other compensation.
Rankings
In 2021, Barry D. Quart's compensation ranked 2,360th out of 12,415 executives tracked by ExecPay. In other words, Quart earned more than 81.0% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 2,360 out of 12,415 | 81st |
Division Manufacturing | 929 out of 5,508 | 83rd |
Major group Chemicals And Allied Products | 353 out of 2,378 | 85th |
Industry group Drugs | 306 out of 2,099 | 85th |
Industry Pharmaceutical Preparations | 198 out of 1,549 | 87th |
Pay ratio
| Barry D. Quart's Pay | $5,430,828 |
|---|---|
| Median Employee's Pay | $268,692 |
| Pay Ratio | 20to 1 |
In 2021, the annual total compensation of Barry D. Quart was $5,430,828.
The annual total compensation of the median employee at Heron Therapeutics was $268,692.
The ratio of Barry D. Quart's pay to the pay of median employee was therefore 20 to one.
Quart's colleagues
We found four more compensation records of executives who worked with Barry D. Quart at Heron Therapeutics in 2021.
News
April 29, 2024
May 1, 2023
April 25, 2022
April 22, 2021
April 23, 2020